Cargando…

Iron deficiency after kidney transplantation

Iron deficiency (ID) is highly prevalent in kidney transplant recipients (KTRs) and has been independently associated with an excess mortality risk in this population. Several causes lead to ID in KTRs, including inflammation, medication and an increased iron need after transplantation. Although man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vinke, Joanna Sophia J, Francke, Marith I, Eisenga, Michele F, Hesselink, Dennis A, de Borst, Martin H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577626/ https://www.ncbi.nlm.nih.gov/pubmed/32910168 http://dx.doi.org/10.1093/ndt/gfaa123

Ejemplares similares

Iron deficiency, with and without anaemia, across strata of kidney function in kidney transplant recipients
por: Ayerdem, Gizem, et al.
Publicado: (2021)

Iron deficiency and cognitive functioning in kidney transplant recipients: findings of the TransplantLines biobank and cohort study
por: Vinke, Joanna Sophia J, et al.
Publicado: (2023)

Type of proton‐pump inhibitor and risk of iron deficiency in kidney transplant recipients – results from the TransplantLines Biobank and Cohort Study
por: Douwes, Rianne M., et al.
Publicado: (2021)

Ferric carboxymaltose and SARS-CoV-2 vaccination-induced immunogenicity in kidney transplant recipients with iron deficiency: The COVAC-EFFECT randomized controlled trial
por: Vinke, Joanna Sophia J., et al.
Publicado: (2023)

Cholesterol Embolization Syndrome After Kidney Transplantation: A Case Series and Systematic Review
por: Francke, Marith I., et al.
Publicado: (2021)

Iron deficiency is related to lower muscle mass in community‐dwelling individuals and impairs myoblast proliferation
por: Vinke, Joanna Sophia J., et al.
Publicado: (2023)

Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019)

Association of Endogenous Erythropoietin Levels and Iron Status With Cognitive Functioning in the General Population
por: Ayerdem, Gizem, et al.
Publicado: (2022)

Decreased haemoglobin levels are associated with lower muscle mass and strength in kidney transplant recipients
por: Vinke, Joanna Sophia J., et al.
Publicado: (2022)

A Population Pharmacokinetic Model of Whole-Blood and Intracellular Tacrolimus in Kidney Transplant Recipients
por: Franken, Linda G., et al.
Publicado: (2022)

Iron Deficiency Defined by Hepcidin in Critically Ill Patients
por: Eisenga, Michele F.
Publicado: (2021)

Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients
por: Francke, Marith I., et al.
Publicado: (2020)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020)

Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx): rationale and study protocol for a double-blind, randomised, placebo-controlled trial
por: Vinke, Joanna SJ, et al.
Publicado: (2023)

Iron Deficiency and Nephrotoxic Heavy Metals: A Dangerous Interplay?
por: Rawee, Pien, et al.
Publicado: (2023)

Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease
por: Eisenga, Michele F., et al.
Publicado: (2018)

Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus
por: Vinke, Joanna Sophia J., et al.
Publicado: (2019)

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study
por: Eisenga, Michele F., et al.
Publicado: (2019)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

Association of hepcidin‐25 with survival after kidney transplantation
por: Eisenga, Michele F., et al.
Publicado: (2016)

Plasma Vitamin C and Cancer Mortality in Kidney Transplant Recipients
por: Gacitúa, Tomás A., et al.
Publicado: (2019)

Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice
por: Francke, Marith I., et al.
Publicado: (2022)

Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial
por: Francke, Marith I., et al.
Publicado: (2021)

Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
por: Francke, M. I., et al.
Publicado: (2022)

Treatment of iron deficiency in patients scheduled for pancreatic surgery: implications for daily prehabilitation practice in pancreatic surgery
por: Wijma, Allard G., et al.
Publicado: (2023)

Plasma Copper Concentration Is Associated with Cardiovascular Mortality in Male Kidney Transplant Recipients
por: Yepes-Calderón, Manuela, et al.
Publicado: (2023)

Urinary Copper Excretion Is Associated with Long-Term Graft Failure in Kidney Transplant Recipients
por: Yepes-Calderón, Manuela, et al.
Publicado: (2023)

Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies
por: Kremer, Daan, et al.
Publicado: (2021)

Sex and N-terminal pro B-type natriuretic peptide: The potential mediating role of iron biomarkers
por: Khatami, Farnaz, et al.
Publicado: (2022)

Vitamin K supplementation and vascular health after kidney transplantation
por: te Velde–Keyzer, CA, et al.
Publicado: (2021)

Costimulation Blockade in Kidney Transplant Recipients
por: van der Zwan, Marieke, et al.
Publicado: (2019)

Plasma Thallium Concentration, Kidney Function, Nephrotoxicity and Graft Failure in Kidney Transplant Recipients
por: Kremer, Daan, et al.
Publicado: (2022)

Natural Antibodies and Alloreactive T Cells Long after Kidney Transplantation
por: van Besouw, Nicole M., et al.
Publicado: (2021)

Direct detection of circulating donor-derived extracellular vesicles in kidney transplant recipients
por: Woud, Wouter W., et al.
Publicado: (2022)

Interleukin-8 Transcripts in Mononuclear Cells Determine Impaired Graft Function after Kidney Transplantation
por: Borst, Christoffer, et al.
Publicado: (2015)

Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation
por: Dedeoglu, Burç, et al.
Publicado: (2016)

Reply to Janssen et al. Comment on “Kremer et al. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Nutrients 2021, 13, 3069”
por: Kremer, Daan, et al.
Publicado: (2022)

Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation
por: van der Zwan, Marieke, et al.
Publicado: (2017)

Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
por: Boer, Karin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g8kjrceu9on1vqkpr0m0dhvutr